Abstract Details
|
M. Amin Banihashemi
PRESENTER |
Mr. Banihashemi has nothing to disclose. |
| Richard H. Swartz, BSc MD PhD FRCPC (Sunnybrook Health Sciences Centre) | The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute. |
| Peter Kertes (University of Toronto) | Peter Kertes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Peter Kertes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Peter Kertes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Peter Kertes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Peter Kertes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Peter Kertes has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Peter Kertes has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Peter Kertes has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis. Peter Kertes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astellas. Peter Kertes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novelty Nobility. Peter Kertes has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Peter Kertes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya. Peter Kertes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Admare Bio-innovations. Peter Kertes has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer. Peter Kertes has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Amgen. The institution of Peter Kertes has received research support from Roche. The institution of Peter Kertes has received research support from Novartis. The institution of Peter Kertes has received research support from Bayer. The institution of Peter Kertes has received research support from RegenxBio. The institution of Peter Kertes has received research support from Johnson and Johnson. The institution of Peter Kertes has received research support from Neuracle Genetics. |
| Wendy Hatch (University of Toronto) | No disclosure on file |
| Christopher Hudson (University of Waterloo) | No disclosure on file |
| Maged Goubran, PhD (Stanford University) | Dr. Goubran has nothing to disclose. |
| Sandra E. Black, MD, FAAN (Sunnybrook Health Science Center) | Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study. |